| pubmed-article:7519671 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7519671 | lifeskim:mentions | umls-concept:C0304925 | lld:lifeskim |
| pubmed-article:7519671 | lifeskim:mentions | umls-concept:C0205145 | lld:lifeskim |
| pubmed-article:7519671 | lifeskim:mentions | umls-concept:C0005456 | lld:lifeskim |
| pubmed-article:7519671 | lifeskim:mentions | umls-concept:C0016321 | lld:lifeskim |
| pubmed-article:7519671 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7519671 | pubmed:dateCreated | 1994-9-6 | lld:pubmed |
| pubmed-article:7519671 | pubmed:abstractText | Human serum albumin is known to have two major and selective drug binding sites, termed sites I and II. The fluorescent probes, dansylamide and dansylsarcosine selectively interact with sites I and II, respectively. However, the binding site of the fluorescent probe dansylglycine on human serum albumin is not clear from the literature. This study investigated whether dansylglycine interacts tightly with site I or II. Spectrofluorimetric titrations (quenching and complex) and circular dichroism measurements were performed to determine the binding characteristics of dansylglycine to human serum albumin. Modification in probe fluorescence was described by fluorescence titrations to be a result of competitive displacement by ligands. The pattern of displacement of this probe by several ligands whose primary binding sites are exactly known, enabled the identification of its specific binding site. The fluorescence of dansylglycine is only extensively changed when ligands of site II are added, suggesting that it strongly interacts with the benzodiazepine/indole binding site on human serum albumin. | lld:pubmed |
| pubmed-article:7519671 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7519671 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7519671 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7519671 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:7519671 | pubmed:issn | 0022-3573 | lld:pubmed |
| pubmed-article:7519671 | pubmed:author | pubmed-author:NetterPP | lld:pubmed |
| pubmed-article:7519671 | pubmed:author | pubmed-author:MullerNN | lld:pubmed |
| pubmed-article:7519671 | pubmed:author | pubmed-author:LapicqueFF | lld:pubmed |
| pubmed-article:7519671 | pubmed:author | pubmed-author:DrelonEE | lld:pubmed |
| pubmed-article:7519671 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7519671 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:7519671 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7519671 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7519671 | pubmed:pagination | 300-4 | lld:pubmed |
| pubmed-article:7519671 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:meshHeading | pubmed-meshheading:7519671-... | lld:pubmed |
| pubmed-article:7519671 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7519671 | pubmed:articleTitle | Binding sites of fluorescent probes on human serum albumin. | lld:pubmed |
| pubmed-article:7519671 | pubmed:affiliation | URA CNRS 1288 Physiopathologie et Pharmacologie Articulaires, Faculté de Médecine, Vandoeuvre les Nancy, France. | lld:pubmed |
| pubmed-article:7519671 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7519671 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7519671 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7519671 | lld:pubmed |
